Home > Press > Trends in Nanotechnology Funding, Research and Business Converge in New Webinar Series
Abstract:
NanoTecNexus announces a new series of business and scientific webinars intended for industry, investment, research, and academic communities. Topics include strategies in funding, regulatory safety, R&D, and commercialization of applications.
Trends in Nanotechnology Funding, Research and Business Converge in New Webinar Series
San Diego, CA | Posted on February 5th, 2010
NanoTecNexus (NTN), already acclaimed for its educational forums and nanotechnology expertise, announces a new series of business and scientific online webinars intended for members of industry, investment, research, and academic communities. Nanotechnology involves the science and technology of devices and materials developed at the molecular scale and poised to revolutionize applications across many industries. Webinar topics planned for release in 2010 include the latest strategies in funding, regulatory issues, safety, research and development, and updates in the commercialization of nanotechnology-based applications.
The business and scientific series of webinars follow the highly successful CME (Continuing Medical Education) Accredited Nanomedicine series produced in partnership with UC San Diego's NanoTumor Center and sponsored by the UC San Diego School of Medicine. Kicking off the new round of business-focused webinars is a lecture on funding strategies entitled "Financing Innovation in Our New World: Utilizing Non-Dilutive Funding for Capital Efficiency" scheduled for Thursday, February 18, 2010 at 11am Pacific. All topics are designed to help attendees navigate through the new rules of doing business in today's volatile economy and discover new opportunities with emerging nanotechnologies.
"Business is fueled by innovation and, despite the economic outlook, access to high caliber expert content remains vital if companies are to emerge and stay competitive," noted Adriana Vela, Founder and CEO of NanoTecNexus. "Our online sessions allow us to leverage experts worldwide and deliver content to a broad and geographically dispersed audience."
A variety of industry tracks showcasing promising companies that are developing nanotech-enabled products are also being planned. Visit www.nanotecnexus.org for schedules and release dates of live and on-demand webinars.
####
About NanoTecNexus
NanoTecNexus (NTN), formerly known as NanoBioNexus, is a leading non-profit organization headquartered in San Diego with offices in Tucson AZ, San Jose, CA and Vancouver, WA. NTN is dedicated to catalyzing collaboration and knowledge exchange in the nanotech field by connecting people, technology, industry and investment. NanoTecNexus enables constituents worldwide to keep up-to-date on the developments of cutting-edge nanotechnologies.
Nanotechnology involves manipulating matter on an atomic or molecular scale smaller than 100 nanometers (1 nm=1 billionths of a meter) and taking advantage of properties that are present at that scale. Nanotechnology is used in thousands of applications in medicine and health, energy and water, defense and many others.
For more information, please click here
Contacts:
Principal Contact
Adriana Vela
(858)-774-8283
Copyright © NanoTecNexus
If you have a comment, please
Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Bookmark:
News and information
Aspen Aerogels Announces $22.5 Million Private Placement May 18th, 2013
NanoInk, Inc. Assets To Be Sold May 18th, 2013
Beautiful "flowers" self-assemble in a beaker: Elaborate nanostructures blossom from a chemical reaction perfected at Harvard May 17th, 2013
Scientists capture first direct proof of Hofstadter butterfly effect May 17th, 2013
Govt.-Legislation/Regulation/Funding/Policy
Beautiful "flowers" self-assemble in a beaker: Elaborate nanostructures blossom from a chemical reaction perfected at Harvard May 17th, 2013
Artificial Forest for Solar Water-Splitting: Berkeley Lab Researchers Report First Fully Integrated Artificial Photosynthesis Nanosystem May 17th, 2013
Moth-Inspired Nanostructures Take the Color Out of Thin Films May 17th, 2013
NIA Public Briefing: Nanotechnology and the Council of Europe May 17th, 2013
Academic/Education
Inaugural Baccalaureate Class Among CNSE Graduates to Pursue Opportunities in New York: Half of undergrads from pioneering class to seek graduate degrees at CNSE; majority of master’s and doctoral degree recipients land high-tech jobs in state’s emerging nanotech industry May 16th, 2013
Anasys reports on University of Illinois study of near-field behavior of semiconductor plasmonic microparticles using AFM-IR published in APL May 14th, 2013
The University of Wyoming uses Nanoparticle Tracking Analysis to characterize nanoparticles in natural environments May 14th, 2013
Nanotechnology Pioneer Named 'Entrepreneur of the Year': Royal Society of Chemistry honors Chad Mirkin for commercializing innovations May 10th, 2013
Investments/IPO's/Splits
Aspen Aerogels Announces $22.5 Million Private Placement May 18th, 2013
Harris & Harris Group Notes the Sale of a Second D-Wave Quantum Computer May 16th, 2013
Nanometrics Announces Upcoming Investor Events May 14th, 2013
Nanostart-holding New Asia Investments invests in breakthrough water projects May 13th, 2013
Announcements
Aspen Aerogels Announces $22.5 Million Private Placement May 18th, 2013
NanoInk, Inc. Assets To Be Sold May 18th, 2013
NIA Public Briefing: Nanotechnology and the Council of Europe May 17th, 2013
Scientists capture first direct proof of Hofstadter butterfly effect May 17th, 2013
Safety-Nanoparticles/Risk management
NIA Public Briefing: Nanotechnology and the Council of Europe May 17th, 2013
Squishy hydrogels may be the ticket for studying biological effects of nanoparticles May 15th, 2013
Ubiquitous engineered nanomaterials cause lung inflammation, study finds: Substances are used in everything from paint to sporting equipment May 6th, 2013
Council of Europe commences regulation of nanotechnology April 27th, 2013